Login to Your Account



Pharmas Add $42M in Merus Series B Extension

By Marie Powers
Staff Writer

Friday, October 4, 2013
Merus BV enticed Johnson & Johnson Development Corp. (JJDC) to join existing investors Novartis Venture Fund and Pfizer Venture Investments for a big pharma trifecta in a 31 million (US$42 million) extension to its Series B financing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription